Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/31273
Title: Investigation of biomarkers regarding their predictive value in the development of gestational diabetes mellitus. An overview
Authors: Lazarou, Eleftheria 
Lambrinou, Ekaterini 
Kolokotroni, Ourania 
Metallinou, Dimitra 
Miltiadous, Panagiota 
Hadjigeorgiou, Eleni 
Major Field of Science: Medical and Health Sciences
Field Category: Clinical Medicine
Keywords: Gestational diabetes mellitus;Pregnancy;Biomarkers;Prediction
Issue Date: 2023
Source: European Journal of Midwifery, 2023, vol. 7, suppl. 1, articl. no. A109
Volume: 7
Issue: Supplement 1
Journal: European Journal of Midwifery 
Abstract: Introduction: Gestational diabetes mellitus (GDM) has been associated with various short- and long-term adverse perinatal outcomes for both mothers and their offspring. Its incidence is estimated to be 14% of all pregnancies worldwide. GDM screening and diagnosis delay as they take place between the 24th and 28th week of gestational age. Discordance among GDM diagnostic criteria has increased research interest regarding biomarkers since they may provide useful information when clinical and laboratory findings are still lacking. The present review provides evidence through an overview of biomarkers investigated in the blood of pregnant women early in pregnancy who subsequently developed GDM. Material and Methods: PubMed and Google Scholar were searched for articles published between 2010 – 2023. Key words ‘’gestational diabetes mellitus’’, ‘’biomarkers’’, ‘’biochemical markers’’, ‘’blood’’, ‘’serum’’, ‘’pregnancy’’, ‘’prediction’’ were used to identify relevant articles. Results: Totally, 12 studies were included. Sex hormone binding globulin (SHBG), Osteocalcin, Follistatin-like 3 (FSTL3), Malondialdehyde (MDA), Glutathione Peroxidase Activity (GPA), Triglyceride, YKL-40, microRNAs, plasma-glycated CD59 (pGCD59), Irisin and Ferritin have been investigated early in pregnancy in the blood of pregnant women who subsequently developed GDM. Osteocalcin, pGCD59, MDA, GPA, microRNA-16-5p, -17-5p and -20a-5p demonstrated higher levels in the serum of GDM-women compared to non-GDM while SHBG, Irisin and FSTL3 demonstrated lower levels. No association was found between YKL-40 serum levels and the early identification of women at risk for GDM. Conclusions: Several potential biomarkers with promising results relating to GDM predictive value have been explored in the blood of pregnant women during early pregnancy. However, currently, an ideal biomarker does not exist. As a result, further research is needed on this topic.
URI: https://hdl.handle.net/20.500.14279/31273
ISSN: 25852906
DOI: 10.18332/ejm/172397
Type: Article
Affiliation : Iasis Private Hospital 
Cyprus University of Technology 
University of West Attica 
Publication Type: Peer Reviewed
Appears in Collections:Άρθρα/Articles

Files in This Item:
File SizeFormat
Article.pdf70.49 kBAdobe PDFView/Open
CORE Recommender
Show full item record

Page view(s)

86
Last Week
0
Last month
5
checked on Dec 3, 2024

Download(s)

58
checked on Dec 3, 2024

Google ScholarTM

Check

Altmetric


Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.